188 related articles for article (PubMed ID: 21624387)
21. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
Uthaug MV; Lancelotta R; van Oorsouw K; Kuypers KPC; Mason N; Rak J; Šuláková A; Jurok R; Maryška M; Kuchař M; Páleníček T; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2019 Sep; 236(9):2653-2666. PubMed ID: 30982127
[TBL] [Abstract][Full Text] [Related]
22. Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine.
Young R; Rosecrans JA; Glennon RA
Pharmacol Biochem Behav; 1986 Dec; 25(6):1207-10. PubMed ID: 3809222
[TBL] [Abstract][Full Text] [Related]
23. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT
Riga MS; Lladó-Pelfort L; Artigas F; Celada P
Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792
[TBL] [Abstract][Full Text] [Related]
24. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder.
Barsuglia JP; Polanco M; Palmer R; Malcolm BJ; Kelmendi B; Calvey T
Prog Brain Res; 2018; 242():121-158. PubMed ID: 30471678
[TBL] [Abstract][Full Text] [Related]
25. A narrative synthesis of research with 5-MeO-DMT.
Ermakova AO; Dunbar F; Rucker J; Johnson MW
J Psychopharmacol; 2022 Mar; 36(3):273-294. PubMed ID: 34666554
[TBL] [Abstract][Full Text] [Related]
26. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
Riga MS; Soria G; Tudela R; Artigas F; Celada P
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1269-82. PubMed ID: 24650558
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
[TBL] [Abstract][Full Text] [Related]
28. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.
Halberstadt AL; Koedood L; Powell SB; Geyer MA
J Psychopharmacol; 2011 Nov; 25(11):1548-61. PubMed ID: 21148021
[TBL] [Abstract][Full Text] [Related]
29. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA
Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638
[TBL] [Abstract][Full Text] [Related]
30. Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.
Wu C; Jiang XL; Shen HW; Yu AM
Biochem Pharmacol; 2009 Sep; 78(6):617-24. PubMed ID: 19445902
[TBL] [Abstract][Full Text] [Related]
31. 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.
Jefferson SJ; Gregg I; Dibbs M; Liao C; Wu H; Davoudian PA; Woodburn SC; Wehrle PH; Sprouse JS; Sherwood AM; Kaye AP; Pittenger C; Kwan AC
Neuropsychopharmacology; 2023 Aug; 48(9):1257-1266. PubMed ID: 37015972
[TBL] [Abstract][Full Text] [Related]
32. Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae).
Schwelm HM; Zimmermann N; Scholl T; Penner J; Autret A; Auwärter V; Neukamm MA
J Anal Toxicol; 2022 May; 46(5):540-548. PubMed ID: 33851996
[TBL] [Abstract][Full Text] [Related]
33. Blockade and reversal of 5-methoxy-N,N-dimethyltryptamine-induced analgesia following noradrenaline depletion.
Archer T; Minor BG; Post C
Brain Res; 1985 Apr; 333(1):55-61. PubMed ID: 3158373
[TBL] [Abstract][Full Text] [Related]
34. Psychedelic N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine modulate innate and adaptive inflammatory responses through the sigma-1 receptor of human monocyte-derived dendritic cells.
Szabo A; Kovacs A; Frecska E; Rajnavolgyi E
PLoS One; 2014; 9(8):e106533. PubMed ID: 25171370
[TBL] [Abstract][Full Text] [Related]
35. A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus.
Helsley S; Fiorella D; Rabin RA; Winter JC
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):649-63. PubMed ID: 9682278
[TBL] [Abstract][Full Text] [Related]
36. Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
Lancelotta RL; Davis AK
J Psychoactive Drugs; 2020; 52(3):273-281. PubMed ID: 32148190
[TBL] [Abstract][Full Text] [Related]
37. A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.
Reckweg J; Mason NL; van Leeuwen C; Toennes SW; Terwey TH; Ramaekers JG
Front Pharmacol; 2021; 12():760671. PubMed ID: 34912222
[TBL] [Abstract][Full Text] [Related]
38. Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.
Darmani NA; Martin BR; Glennon RA
Pharmacol Biochem Behav; 1992 Mar; 41(3):519-27. PubMed ID: 1584831
[TBL] [Abstract][Full Text] [Related]
39. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
Commissaris RL; Davis M
Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
[TBL] [Abstract][Full Text] [Related]
40. Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT.
Dakic V; Minardi Nascimento J; Costa Sartore R; Maciel RM; de Araujo DB; Ribeiro S; Martins-de-Souza D; Rehen SK
Sci Rep; 2017 Oct; 7(1):12863. PubMed ID: 28993683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]